Generation of CD8+ T Cells Specific for Transporter Associated with Antigen Processing Deficient Cells
Overview
Affiliations
Cells with impaired transporter associated with antigen processing (TAP) function express low levels of cell surface major histocompatibility complex (MHC) class I molecules, and are generally resistant to lysis by MHC class I restricted cytotoxic T lymphocytes (CTLs). Here we report the generation of MHC class I restricted CD8(+) CTLs that surprisingly require target cell TAP deficiency for efficient recognition. C57BL/6 (B6) mice immunized with syngenic B7-1 (CD80) expressing TAP-deficient cells generated a potent CTL response against both TAP-deficient RMA-S tumor cells and TAP-deficient Con A blasts, whereas the corresponding TAP-expressing target cells were considerably less susceptible or resistant to lysis. The CTL epitopes recognized were expressed also by the human TAP-deficient cell line T2, transfected with appropriate MHC class I molecules. B6 mice immunized with B7-1-transfected TAP-deficient RMA-S cells were protected from outgrowth of a subsequent RMA-S tumor challenge. These findings are discussed in relation to the biochemical nature of MHC class I dependent CTL epitopes associated with impaired TAP function, as well as implications for immunotherapy and autoimmunity.
Occlusion of TCR binding to HLA-A*11:01 by a non-pathogenic human alloantibody.
Hamidinia M, Gu Y, Ser Z, Brzostek J, Tay N, Yap J Cell Mol Life Sci. 2025; 82(1):94.
PMID: 40009199 PMC: 11865395. DOI: 10.1007/s00018-025-05614-y.
Allosteric inhibition of the T cell receptor by a designed membrane ligand.
Ye Y, Morita S, Chang J, Buckley P, Wilhelm K, DiMaio D Elife. 2023; 12.
PMID: 37796108 PMC: 10554751. DOI: 10.7554/eLife.82861.
Sandalova T, Sala B, Achour A Front Chem. 2022; 10:861609.
PMID: 36017166 PMC: 9395651. DOI: 10.3389/fchem.2022.861609.
Spotlight on TAP and its vital role in antigen presentation and cross-presentation.
Mantel I, Sadiq B, Blander J Mol Immunol. 2022; 142:105-119.
PMID: 34973498 PMC: 9241385. DOI: 10.1016/j.molimm.2021.12.013.
MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It.
Shklovskaya E, Rizos H Int J Mol Sci. 2021; 22(13).
PMID: 34201655 PMC: 8268865. DOI: 10.3390/ijms22136741.